Global & U.S. CIPN Treatment Markets, 2027 - Calcium Channel A2-Delta Ligands Segment Anticipated to Hold the Largest Share (~34.7%), Owing to High Adoption for the Treatment of CIPN

/PRNewswire/ -- The "Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment Market, By Type, By Application, Estimation & Forecast, 2017-2027"...

Related Keywords

Japan ,United States ,Dublin ,Ireland ,America ,American ,Apexian Pharma ,Laura Wood ,Asahi Kasei Pharma Corp ,Market Development ,Nemus Bioscience Inc ,National Cancer Institute ,Office Hours Call ,Kineta Inc ,Metys Pharmaceuticals ,Sova Pharmaceuticals Inc ,E St Office Hours Call ,Regenacy Pharmaceuticals ,Aptinyx Inc ,Maruho Co Ltd ,Product Development Innovation ,American Cancer Society ,Induced Peripheral Neuropathy Treatment Market ,Induced Peripheral Neuropathy Treatment ,North America ,Middle East ,Asia Pacific ,Solasia Pharma ,Landscape Assessment ,Senior Manager ,Free Call ,Hours Call ,Research And Markets ,